Respiratory bacterial infections in cystic fibrosis
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Respiratory bacterial infections in cystic fibrosis. / Ciofu, Oana; Hansen, Christine R; Høiby, Niels.
In: Current Opinion in Pulmonary Medicine, Vol. 19, No. 3, 05.2013, p. 251-8.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Respiratory bacterial infections in cystic fibrosis
AU - Ciofu, Oana
AU - Hansen, Christine R
AU - Høiby, Niels
PY - 2013/5
Y1 - 2013/5
N2 - PURPOSE OF REVIEW: Bacterial respiratory infections are the main cause of morbidity and mortality in patients with cystic fibrosis (CF). Pseudomonas aeruginosa remains the main pathogen in adults, but other Gram-negative bacteria such as Achromobacter xylosoxidans and Stenotrophomonas maltophilia as well as nontuberculous mycobacteria have been shown to play an important role in the lung disease. The purpose of this review is to summarize the knowledge on disease and treatment of infection with CF-related pathogens.RECENT FINDINGS: The role of the paranasal sinuses as a source of infection and site of bacterial adaptation has been recognized. This review will focus on the different conditions encountered by the bacteria in sinuses and lung, as well as the principles of treatment in the different infection sites.SUMMARY: Chronic, pulmonary infections remain the single most prominent cause of the increased morbidity and mortality in CF. After the increasing efficiency of anti-P. aeruginosa treatment, newer pathogens have been identified, with individual clinical characteristics. Microbiological surveillance is very important in keeping the patients stable. Samples from both the lower and upper respiratory tract (nasal sampling) should be investigated and both infection sites should be treated.
AB - PURPOSE OF REVIEW: Bacterial respiratory infections are the main cause of morbidity and mortality in patients with cystic fibrosis (CF). Pseudomonas aeruginosa remains the main pathogen in adults, but other Gram-negative bacteria such as Achromobacter xylosoxidans and Stenotrophomonas maltophilia as well as nontuberculous mycobacteria have been shown to play an important role in the lung disease. The purpose of this review is to summarize the knowledge on disease and treatment of infection with CF-related pathogens.RECENT FINDINGS: The role of the paranasal sinuses as a source of infection and site of bacterial adaptation has been recognized. This review will focus on the different conditions encountered by the bacteria in sinuses and lung, as well as the principles of treatment in the different infection sites.SUMMARY: Chronic, pulmonary infections remain the single most prominent cause of the increased morbidity and mortality in CF. After the increasing efficiency of anti-P. aeruginosa treatment, newer pathogens have been identified, with individual clinical characteristics. Microbiological surveillance is very important in keeping the patients stable. Samples from both the lower and upper respiratory tract (nasal sampling) should be investigated and both infection sites should be treated.
KW - Anti-Infective Agents
KW - Bacterial Infections
KW - Chronic Disease
KW - Cystic Fibrosis
KW - Humans
KW - Lung
KW - Paranasal Sinuses
KW - Pseudomonas aeruginosa
KW - Respiratory Tract Infections
U2 - 10.1097/MCP.0b013e32835f1afc
DO - 10.1097/MCP.0b013e32835f1afc
M3 - Journal article
C2 - 23449384
VL - 19
SP - 251
EP - 258
JO - Current Opinion in Pulmonary Medicine
JF - Current Opinion in Pulmonary Medicine
SN - 1070-5287
IS - 3
ER -
ID: 117485562